H.C. Wainwright maintained its Buy rating and $4.00 price target for Hoth Therapeutics (NASDAQ:HOTH), following the company's announcement of securing a U.S. patent for its Alzheimer's disease (AD ...
The HOTH announces significant expansion of its client portfolio, crediting its success to continuous innovation in SEO techniques and client-focused approach. St. Petersburg, Florida, United ...
Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic ...
NEW YORK - Hoth Therapeutics , Inc. (NASDAQ: NASDAQ:HOTH) has been granted a U.S. patent for HT-ALZ, a novel Alzheimer's treatment. This development marks a significant step for the clinical-stage ...
The HOTH announces significant expansion of its client portfolio, crediting its success to continuous innovation in SEO techniques and client-focused approach. The HOTH, a leading SEO company ...
If you want to foster your child’s independent learning and play, Montessori-inspired toys can help them confidently engage with the world on their own. Sami Krasny, a play-based education ...
Short interest in Hoth Therapeutics Inc (NASDAQ:HOTH) increased during the last reporting period, rising from 212.46K to 219.36K. This put 3.2% of the company's publicly available shares short.